PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses

Tumor-specific neoantigens can be highly immunogenic, but their identification for each patient and the production of personalized cancer vaccines can be time-consuming and prohibitively expensive. In contrast, tumor-associated antigens are widely expressed and suitable as an off the shelf immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Dölen, Yusuf, Gileadi, Uzi, Chen, Ji-Li, Valente, Michael, Creemers, Jeroen H. A., Van Dinther, Eric A. W., van Riessen, N. Koen, Jäger, Eliezer, Hruby, Martin, Cerundolo, Vincenzo, Diken, Mustafa, Figdor, Carl G., de Vries, I. Jolanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947615/
https://www.ncbi.nlm.nih.gov/pubmed/33717196
http://dx.doi.org/10.3389/fimmu.2021.641703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947615/
https://www.ncbi.nlm.nih.gov/pubmed/33717196
http://dx.doi.org/10.3389/fimmu.2021.641703

Ejemplares similares